1. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network Asthma and COPD Market Size is Projected to Experience Significant Growth from 2017 to 2024.: Global Market Insights Inc.

2. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Rising prevalence of the respiratory diseases, growing pathogens in environment leading to chronic conditions such as, chronic obstructive pulmonary disease (COPD) and asthma are the major growth driving factors.  These conditions require lifelong medications as a result medical adherence is extremely necessary, in addition, the reduction in quality of life are some aspects that fuel the Asthma and COPD Market growth over the forecast period.  These chronic respiratory diseases are caused by numerous environmental factors or are genetically acquired requires constant care management.  As per WHO in 2015, approximately 3 million deaths were caused due to COPD, being the progressive and life-threatening disease of lungs, this accounts for around 5% of the total global deaths per year. Brief Detail of Asthma and COPD Market :

3. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Moreover, the supporting initiatives by private and public institutions adds up to the asthma and COPD market size growth during the forecast timeframe.  For instance, the Global Asthma Network (GAN) along with the International Union against Tuberculosis and lung disease and the International Study of Asthma and Allergies in Childhood (ISAAC) aims reduction in asthma suffering.  This is done by the improvement in respiratory care globally and are more focused on the low and middle-income nations. The increase in adoption rate of products thereby, provide business growth.

4. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Inhalers includes metered dose inhalers (MDIs), soft mist inhalers (SMIs), and drug powder inhalers (DPIs). DPIs accounted for major share in 2016 due to the advantages such as less patient coordination required, compactness, appropriate for emergency circumstances, and portability are some aspects that encourages the patients’ buying preferences.  U.S. led the asthma and COPD market owing to strong pipeline for novel therapies, technological advancements, and growing disease prevalence. According to, the CDC, in 2014, around 15.7 million Americans were detected with COPD, that accounts for 6.4% people of the total population. India and China are growing significantly due to increase in disease prevalence. These nations have opportunity to grow their business rapidly as some of the European pharmaceutical companies are on the edge of expiration in terms of numerous patents. Regional Analysis of Asthma and COPD Market

5. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Browse Full Market Research Report On Asthma and COPD Market @ http://bit.ly/2vhtvFchttp://bit.ly/2vhtvFc Request for an in-depth table of contents for this report @ http://bit.ly/2vshtte http://bit.ly/2vshtte

6. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Stay In Touch Website: www.gminsights.comwww.gminsights.com Social Media: